Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

CUSIP: 23954D109

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
101,960,784
Total 13F shares
76,570,666
Share change
-4,213,219
Total reported value
$1,117,957,204
Put/Call ratio
181%
Price per share
$14.60
Number of holders
138
Value change
-$50,224,829
Number of buys
71
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP 23954D109?
CUSIP 23954D109 identifies DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q4 2023

As of 31 Dec 2023, Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 76,570,666 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Atlas Venture Life Science Advisors, LLC, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BRAIDWELL LP, FMR LLC, STATE STREET CORP, Pictet Asset Management Holding SA, and VIKING GLOBAL INVESTORS LP. This page lists 138 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.